Lexicon Pharmaceuticals

LXRX · NASDAQ

$1.58+$0.03 (+1.94%)TodayMarket closed ·
Prev close $1.55

Who owns LXRX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 77.1% of LXRX’s shares.

  • Artal International S.C.A.39.4%
  • Fidelity Management & Research Company LLC11.7%
  • Invus Public Equities Advisors, LLC10.0%
  • Sessa Capital4.3%
  • Next 6 largest institutions11.8%
  • All other shareholders22.9%
Top institutional holders of LXRX
HolderShares% of shares
Artal International S.C.A.175.16M39.43%
Fidelity Management & Research Company LLC51.78M11.66%
Invus Public Equities Advisors, LLC44.30M9.97%
Sessa Capital18.96M4.27%
BlackRock Institutional Trust Company, N.A.15.91M3.58%
Vanguard Capital Management, LLC9.90M2.23%
Point72 Asset Management, L.P.8.25M1.86%
Ulys, L.L.C.6.99M1.57%
Geode Capital Management, L.L.C.6.24M1.41%
State Street Investment Management (US)4.92M1.11%

Largest mutual fund holders

Top mutual fund holders of LXRX
HolderShares% of shares
Fidelity Growth Company Fund19.05M4.29%
Vanguard Total Stock Market Index Fund7.08M1.59%
iShares Russell 2000 ETF6.30M1.42%
Fidelity Growth Company K6 Fund5.60M1.26%
Fidelity Series Growth Company Fund4.56M1.03%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of LXRX in the last 6 months.

Latest LXRX insider transactions
InsiderTypeSharesValue
Swain Judith LOption exercise89.31K—
Swain Judith LOption exercise89.31K—
Sullivan Diane E.Option exercise89.31K—
Sullivan Diane E.Option exercise89.31K—
Cheung IvanOption exercise89.31K—
Cheung IvanOption exercise89.31K—
BARKER SAM LOption exercise89.31K—
BARKER SAM LOption exercise89.31K—
Amouyal PhilippeOption exercise89.31K—
Amouyal PhilippeOption exercise89.31K—

Short interest

Settled Sep 30, 2026

Shares short
25.83M
Days to cover
6.16
% of shares outstanding
5.81%
Average daily volume
4.19M
Change since last report
−10.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.